And, how ethical would it be for a company to withhold positive data? I doubt seriously that, if such a claim is true, the offender paid any money to CYDY for the leronlimab used in the study - I don't recall seeing any income from such a source, but I'm admittedly not much for analysis of financial statements.

Should this suggestion be true I hope we learn the offender's identity and that they would have their pants sued off like our supposed CRO.